Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000993390 | SCV001146324 | uncertain significance | not provided | 2018-11-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000993390 | SCV001988673 | uncertain significance | not provided | 2019-04-25 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Missense variant in a gene in which most reported pathogenic variants are truncating; Has not been previously published as pathogenic or benign to our knowledge |
New York Genome Center | RCV003227883 | SCV003925107 | uncertain significance | Dilated cardiomyopathy 1G; Hypertrophic cardiomyopathy 9 | 2022-05-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004544993 | SCV004780308 | uncertain significance | TTN-related disorder | 2023-10-27 | no assertion criteria provided | clinical testing | The TTN c.15148G>T variant is predicted to result in the amino acid substitution p.Gly5050Trp. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |